This thread is what made me stop lurking and opening an account.
The claim of stock manipulation is too often used to explain poor share price performance. Simple question how does someone benefit from driving a share price down? Unless they are short it makes no sense. When it comes to a stock like UCM it really comes down to the business itself.
1. The business does not have recurring income streams, its has to continually find new buyers for its device. It has no consumable or software as a service component. That is what the market is interested in.
2. UCM has been around for a time now and it has simply failed to ever deliver. Over time they have released countless scientific papers on the benefits of the existing device but they have never been able to find a market. A major has never partnered with them, this endorses a product.
3. As per above, their has been the odd spike from time to time but it has always then failed to back it up via the 4c. You could see it when the June quarterly was released, there was expectation of a good 4c, stock rallied to around 27 but the 4c failed to deliver, there was no quarter on quarter growth so it got sold of. Market manipulation? No a failure to deliver.
4. Geopolitical - the relationship between the west is not good at the moment so there are concerns about companies with exposure to China where they can be bullied by the CCP. Big miners are immune because there is no where else to go but smaller companies could become footballs and as things stand China is the only market UCM has any material exposure to.
So please don't use poor share price performance as an excuse to cry market manipulation, its just poor analysis. UCM has some good potential but it has to be able to sell its products and that has been its problem for nearly 20 years.
- Forums
- ASX - By Stock
- UCM
- ASX Business Rule 2.2.4 Prevention of manipulative trading - a solution
UCM
uscom limited
Add to My Watchlist
0.00%
!
1.9¢

ASX Business Rule 2.2.4 Prevention of manipulative trading - a solution, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 46000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 0.014 |
1 | 132270 | 0.012 |
1 | 100000 | 0.010 |
1 | 150000 | 0.008 |
2 | 2000000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 46000 | 1 |
0.020 | 63256 | 1 |
0.021 | 24866 | 1 |
0.022 | 6549 | 1 |
0.055 | 95083 | 2 |
Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online